New Enterprise Associates 16, L.P. 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-12-29 4:01 pm Sale |
2023-12-21 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
New Enterprise Associates 16, L.P. | 0 0.000% |
-2,186,243![]() (Position Closed) |
Filing |
2023-06-23 2:32 pm Sale |
2023-06-13 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
New Enterprise Associates 16, L.P. | 2,186,243 5.800% |
-2,000,000![]() (-47.78%) |
Filing |